Composition
- Active ingredients
- CLAVULANATE POTASSIUM EQ 1GM BASE/VIAL; TICARCILLIN DISODIUM EQ 30GM BASE/VIAL
Strengths and forms
The FDA lists each strength of a product separately; these pages share one label.
- CLAVULANATE POTASSIUM EQ 100MG BASE/VIAL; TICARCILLIN DISODIUM EQ 3GM BASE/VIAL · InjectableANDA062691-001 · Discontinued
- CLAVULANATE POTASSIUM EQ 1GM BASE/VIAL; TICARCILLIN DISODIUM EQ 30GM BASE/VIAL · InjectableThis page
- CLAVULANATE POTASSIUM EQ 100MG BASE/VIAL; TICARCILLIN DISODIUM EQ 3GM BASE/VIAL · InjectableNDA050590-001 · Discontinued
- CLAVULANATE POTASSIUM EQ 200MG BASE/VIAL; TICARCILLIN DISODIUM EQ 3GM BASE/VIAL · InjectableNDA050590-002 · Discontinued
Official product information
Drugs@FDA lists the approved labels, letters and reviews for application NDA050590.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Brand name
- Timentin
- Active substance
- clavulanate potassium
- Route
- Injection
- Dosage form
- Injectable
- Applicant
- Glaxosmithkline
- Status
- Discontinued
- FDA approval
- 1 Apr 1985
- Application
- NDA050590-003